| 000 | 01361 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511154532.0 | ||
| 264 | 0 | _c19770929 | |
| 008 | 197709s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHacker, M | |
| 245 | 0 | 0 |
_aVM26-induced changes in hepatic intermediary metabolism of mice. _h[electronic resource] |
| 260 |
_bCancer research _cSep 1977 |
||
| 300 |
_a3287-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlood Glucose |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucose _xmetabolism |
| 650 | 0 | 4 |
_aHexosephosphates _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsocitrates _xmetabolism |
| 650 | 0 | 4 |
_aKetoglutaric Acids _xmetabolism |
| 650 | 0 | 4 |
_aLeukemia L1210 _xdrug therapy |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Inbred DBA |
| 650 | 0 | 4 |
_aMitochondria, Liver _xdrug effects |
| 650 | 0 | 4 | _aOxygen Consumption |
| 650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
| 650 | 0 | 4 |
_aSuccinates _xmetabolism |
| 650 | 0 | 4 |
_aTeniposide _xadministration & dosage |
| 700 | 1 | _aRoberts, D | |
| 773 | 0 |
_tCancer research _gvol. 37 _gno. 9 _gp. 3287-92 |
|
| 999 |
_c892239 _d892239 |
||